Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma

Neoplasia

Volumn 7, Issue 1, 2005, Pages 37-47

  Ferrer, Paula ^a   Asensi, Miguel ^a   Segarra, Ramón ^a   Ortega, Angel ^a   Benlloch, María ^a   Obrador, Elena ^a   Varea, María T ^a   Asensio, Gregorio ^a   Jordá, Leonardo ^b   Estrela, José M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Valefarma SA   (Spain)

Author keywords

Melanoma; Metastases; Polyphenols; Pterostilbene; Quercetin

Indexed keywords

CELL ADHESION MOLECULE; MESSENGER RNA; POLYPHENOL; PROTEIN BCL 2; PTEROSTILBENE; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM; FLOW CYTOMETRY; HALF LIFE TIME; LIQUID CHROMATOGRAPHY; LIVER SINUSOID; MALE; MASS SPECTROMETRY; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 13444252223     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04337     Document Type: Article

References (55)

1. Yang CS, Landau JM, Huang MT, and Newmark HL (2001). Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21, 381-406.
2. Ross JA and Kasum CM (2002). Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22, 19-34.
3. Pervaiz S (2003). Resveratrol: from grapevines to mammalian biology. FASEB J 17, 1975-1985.
4. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
5. Fontecave M, Lepoivre M, Elleingand E, Gerez C, and Guittet O (1998). Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421, 277-279.
6. Sun NJ, Woo SH, Cassady JM, and Snapka RM (2003). DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 66, 734.
7. Stewart JR, Ward NE, Ioannides CG, and O'Brian CA (1999). Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry 38, 13244-13251.
8. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, and Dannenberg AJ (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273, 21875-21882.
9. Sauer H, Wartenberg M, and Hescheler J (2001). Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11, 173-186.
10. Clement MV, Hirpara JL, Chawdhury SH, and Pervaiz S (1998). Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
11. She QB, Bode AM, Ma WY, Chen NY, and Dong Z (2001). Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61, 1604-1610.
12. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A, and Greil R (2001). Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 15, 1613-1615.
13. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, and Ghidoni R (2003). Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 17, 2339-2341.
14. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, and Estrela JM (2002). Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33, 387-398.
15. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, et al. (2001). Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276, 22586-22594.
16. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, and Duke SO (2002). Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50, 3453-3457.
17. Lamson DW and Brignall MS (2000). Antioxidants and cancer: Part 3. Quercetin. Altern Med Rev 5, 196-208.
18. Tuck KL, Tan HW, and Hayball PJ (2000). A simple procedure for the deuteriation of phenols. J Label Compd Radiopharm 43, 817-823.
19. Navarro J, Obrador E, Pellicer JA, Aseni M, Vina J, and Estrela JM (1997). Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med 22, 1203-1209.
20. Carretero J, Obrador E, Esteve JM, Ortega A, Pellicer JA, Sempere FV, and Estrela JM (2001). Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J Biol Chem 276, 25775-25782.
21. Anasagasti MJ, Martin JJ, Mendoza L, Obrador E, Estrela JM, McCuskey RS, and Vidal-Vanaclocha F (1998). Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 27, 1249-1256.
22. Carretero J, Obrador E, Anasagasti MJ, Martin JJ, Vidal-Vanaclocha F, and Estrela JM (1999). Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin Exp Metastasis 17, 567-574.
23. Ohigashi H, Shinkai K, Mukai M, Ishikawa O, Imaoka S, Iwanaga T, and Akedo H (1989). In vitro invasion of endothelial cell monolayer by rat ascites hepatoma cells. Jpn J Cancer Res 80, 818-821.
24. Berenbaum MC (1985). The expected effect of a combination of agents: the general solution. J Theor Biol 114, 413-431.
25. Braman RS and Hendrix SA (1989). Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 61, 2715-2718.
26. Okahara H, Yagita H, Miyake K, and Okumura K (1994). Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 54, 3233-3236.
27. Obrador E, Carretero J, Esteve JM, Pellicer JA, Pascual A, Petschen I, and Estrela JM (2001). Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Radic Biol Med 31, 642-650.
28. Eissa S and Seada LS (1998). Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin Chem 44, 1423-1429.
29. Ortega AL, Carretero J, Obrador E, Gambini J, Asensi M, Rodilla V, and Estrela JM (2003). Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. J Biol Chem 278, 13888-13897.
30. Kimura AK and Xiang JH (1986). High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants. J Natl Cancer Inst 76, 1247-1254.
31. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, and Willett WC (1996). Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125, 384-389.
32. Day AJ, Bao Y, Morgan MR, and Williamson G (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29, 1234-1243.
33. Goldberg DM, Van J, and Soleas GJ (2003). Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36, 79-87.
34. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, and Nance DM (2000). Interactions between cancer cells and the endothelium in metastasis. J Pathol 190, 310-329.
35. Ortega A, Ferrer P, Carretero J, Obrador E, Asensi M, Pellicer JA, and Estrela JM (2003). Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. J Biol Chem 278, 39591-39599.
36. Carretero J, Obrador E, Esteve JM, Ortega A, Pellicer JA, Sempere FV, and Estrela JM (2001). Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J Biol Chem 276, 25775-25782.
37. Fidler IJ (1989). Origin and biology of cancer metastasis. Cytometry 10, 673-680.
38. Fremont L (2000). Biological effects of resveratrol. Life Sci 66, 663-673.
39. Soleas GJ, Diamandis EP, and Goldberg DM (2001). The world of resveratrol. Adv Exp Med Biol 492, 159-182.
40. Yoshida M, Yamamoto M, and Nikaido T (1992). Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 52, 6676-6681.
41. Shen F, Herenyiova M, and Weber G (1999). Synergistic downregulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Life Sci 64, 1869-1876.
42. Casagrande F and Darbon JM (2001). Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61, 1205-1215.
43. Williams RJ, Spencer JP, and Rice-Evans C (2004). Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838-849.
44. Fidler IJ (1989). Origin and biology of cancer metastasis. Cytometry 10, 673-680.
45. Hsieh TC, Juan G, Darzynkiewicz Z, and Wu JM (1999). Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 59, 2596-2601.
46. Mendoza L, Olaso E, Anasagasti MJ, Fuentes AM, and Vidal-Vanaclocha F (1998). Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver. J Cell Physiol 174, 322-330.
47. Garofalo A, Chirivi RG, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing AJ, Sanchez-Madrid F, Dejana E, et al. (1995). Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 55, 414-419.
48. Shen SC, Chen YC, Hsu FL, and Lee WR (2003). Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem 89, 1044-1055.
49. Zhang X, Xu Q, and Saiki I (2000). Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression. Clin Exp Metastasis 18, 415-421.
50. Tessitore L, Davit A, Sarotto I, and Caderni G (2000). Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21, 1619-1622.
51. Mahyar-Roemer M, Kohler H, and Roemer K (2002). Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2, 27.
52. Igura K, Ohta T, Kuroda Y, and Kaji K (2001). Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171, 11-16.
53. Bravo L (1998). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317-333.
54. Walle T (2004). Absorption and metabolism of flavonoids. Free Radic Biol Med 36, 829-837.
55. Davies KJ (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61, 1-31.